- ISIN
- US26924G7631
- CUSIP
- 26924G763
- Issuer
- Amplify
- Inception Date
- Jun 17, 2020
- Region
- North America (U.S.)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- Prime Treatments, Testing and Advancements Index
- Domicile
- United States
- Distribution Policy
- Accumulating
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $10M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GERM Performance Chart
Amplify Treatments, Testing and Advancements ETF (GERM) is up 0.0% since the beginning of the year. GERM is currently trading at $19 per share.
Loading charts...
Returns By Period
Amplify Treatments, Testing and Advancements ETF (GERM) has returned 0.00% so far this year and 0.00% over the past 12 months.
Amplify Treatments, Testing and Advancements ETF
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
GERM Monthly Returns History
Based on dividend-adjusted daily data since Sep 6, 2024, GERM's average daily return is 0.00%, while the average monthly return is 0.00%.
Historically, 0% of months were positive and 100% were negative. The best month was Sep 2024 with a return of 0.0%, while the worst month was Sep 2024 at 0.0%. The longest winning streak lasted 0 consecutive months, and the longest losing streak was 0 months.
On a daily basis, GERM closed higher 0% of trading days. The best single day was Sep 6, 2024 with a return of 0.0%, while the worst single day was Sep 6, 2024 at 0.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||||
| 2025 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Benchmark Metrics
0- Alpha
- 0.00%
- Beta
- 0.00
- Upside Capture
- 0.00%
- Downside Capture
- -0.00%
Expense Ratio
GERM has an expense ratio of 0.68%, placing it in the medium range.
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERM | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.37 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.78 | — |
| Martin ratioReturn relative to average drawdown | — | 12.44 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Amplify Treatments, Testing and Advancements ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The portfolio has not yet recovered.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|
Drawdown Indicators
| GERM | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -56.78% | +56.78% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -9.10% | +9.10% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.80% | +1.80% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -10.71% | +10.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 2.03% | -2.03% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with GERM
Add Amplify Treatments, Testing and Advancements ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GERM